- Stocks
- Healthcare
- NASDAQ: CLOV

Price (delayed)

$2.77

Market cap

$1.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.27

Enterprise value

$1.13B

Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral

Clover Health Investments's gross margin has surged by 133% YoY and by 7% QoQ

Clover Health Investments's quick ratio has surged by 100% YoY and by 14% QoQ

The revenue has contracted by 29% YoY but it has grown by 2.2% from the previous quarter

What are the main financial stats of CLOV

Market
Valuations
Earnings

Shares outstanding

497.47M

Market cap

$1.38B

Enterprise value

$1.13B

Price to earnings (P/E)

N/A

Price to book (P/B)

4.23

Price to sales (P/S)

0.8

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

0.66

Revenue

$1.7B

EBIT

-$123.7M

EBITDA

-$121.82M

Free cash flow

-$178.21M

Per share
Balance sheet
Liquidity

EPS

-$0.27

Free cash flow per share

-$0.37

Book value per share

$0.65

Revenue per share

$3.48

TBVPS

$1.38

Total assets

$674.21M

Total liabilities

$349.32M

Debt

$4.01M

Equity

$324.89M

Working capital

$225.07M

Debt to equity

0.01

Current ratio

1.69

Quick ratio

1.44

Net debt/EBITDA

2.06

Margins
Efficiency
Dividend

EBITDA margin

-7.2%

Gross margin

18.6%

Net margin

-7.3%

Operating margin

-7.2%

Return on assets

-16.6%

Return on equity

-40.4%

Return on invested capital

-115.9%

Return on capital employed

-35.4%

Return on sales

-7.3%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Clover Health Investments stock price performed over time

Intraday

4.53%

1 week

4.14%

1 month

48.13%

1 year

108.27%

YTD

190.94%

QTD

125.2%

How have Clover Health Investments's revenue and profit performed over time

Revenue

$1.7B

Gross profit

$315.34M

Operating income

-$122.65M

Net income

-$123.7M

Gross margin

18.6%

Net margin

-7.3%

Clover Health Investments's gross margin has surged by 133% YoY and by 7% QoQ

The gross profit has surged by 65% year-on-year and by 9% since the previous quarter

The operating income has soared by 58% YoY and by 23% from the previous quarter

The net income has soared by 53% year-on-year and by 23% since the previous quarter

What is Clover Health Investments's growth rate over time

What is Clover Health Investments stock price valuation

P/E

N/A

P/B

4.23

P/S

0.8

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

0.66

CLOV's EPS has surged by 52% year-on-year and by 21% since the previous quarter

The P/B is 153% above the last 4 quarters average of 1.6

The equity has grown by 11% from the previous quarter

The P/S is 153% above the last 4 quarters average of 0.3 but 42% below the 5-year quarterly average of 1.3

The revenue has contracted by 29% YoY but it has grown by 2.2% from the previous quarter

How efficient is Clover Health Investments business performance

CLOV's ROE is up by 46% YoY and by 22% from the previous quarter

The return on invested capital is up by 45% year-on-year and by 35% since the previous quarter

CLOV's return on sales is up by 33% year-on-year and by 24% since the previous quarter

The ROA has grown by 19% YoY and by 8% from the previous quarter

What is CLOV's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CLOV.

How did Clover Health Investments financials performed over time

CLOV's total assets is 93% greater than its total liabilities

Clover Health Investments's quick ratio has surged by 100% YoY and by 14% QoQ

Clover Health Investments's total liabilities has plunged by 62% YoY and by 8% from the previous quarter

The debt is 99% less than the equity

The debt to equity has plunged by 50% YoY

The debt has contracted by 25% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.